Randomized, Single-Masked, Long-Term, Safety and Tolerability Study of VEGF Trap-Eye in AMD

ClinicalTrials.gov ID: NCT00527423

Public ClinicalTrials.gov record NCT00527423. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 23, 2026, 2:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Single-Masked , Long-Term, Safety and Tolerability Study of Intravitreal VEGF Trap-Eye in Subjects With Neovascular Age-related Macular Degeneration

Study identification

NCT ID: NCT00527423
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Regeneron Pharmaceuticals; Industry
Enrollment: 157 participants

Conditions and interventions

Conditions

Macular Degeneration

Interventions

VEGF Trap Eye Drug

Drug

Eligibility (public fields only)

Age range: 50 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 31, 2007
Primary completion: Sep 30, 2011
Completion: Sep 30, 2011
Last update posted: Jun 11, 2013

2007 – 2011

United States locations

U.S. sites: 33
U.S. states: 18
U.S. cities: 33

Facility	City	State	ZIP	Site status
Not listed	Peoria	Arizona	85381	—
Not listed	Phoenix	Arizona	85020	—
Not listed	Tucson	Arizona	85704	—
Not listed	Beverly Hills	California	90211	—
Not listed	Loma Linda	California	92354	—
Not listed	Palm Springs	California	92262	—
Not listed	Pasadena	California	91105	—
Not listed	Poway	California	92064	—
Not listed	Westlake Village	California	91361	—
Not listed	Fort Myers	Florida	33912	—
Not listed	Stuart	Florida	34994	—
Not listed	Winter Haven	Florida	33880	—
Not listed	Augusta	Georgia	30909	—
Not listed	Glenview	Illinois	60026	—
Not listed	Indianapolis	Indiana	47280	—
Not listed	Baltimore	Maryland	21287	—
Not listed	Hagerstown	Maryland	21740	—
Not listed	Boston	Massachusetts	02114	—
Not listed	West Springfield	Massachusetts	01089	—
Not listed	Toms River	New Jersey	08755	—
Not listed	Lynbrook	New York	11563	—
Not listed	Charlotte	North Carolina	28210	—
Not listed	Oklahoma City	Oklahoma	73104	—
Not listed	Portland	Oregon	97210	—
Not listed	West Columbia	South Carolina	29169	—
Not listed	Rapid City	South Dakota	57701	—
Not listed	Nashville	Tennessee	37203	—
Not listed	Austin	Texas	78705	—
Not listed	Fort Worth	Texas	76102	—
Not listed	Houston	Texas	77030	—
Not listed	McAllen	Texas	78503	—
Not listed	San Antonio	Texas	78240	—
Not listed	Salt Lake City	Utah	84107	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00527423, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 11, 2013 · Synced Jul 23, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00527423 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →